284 related articles for article (PubMed ID: 30626457)
1. Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality.
Törnkvist PBS; Haupt TH; Rasmussen LJH; Ladelund S; Toft U; Pisinger C; Eugen-Olsen J
Br J Nutr; 2019 Mar; 121(6):699-708. PubMed ID: 30626457
[TBL] [Abstract][Full Text] [Related]
2. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
Persson M; Engström G; Björkbacka H; Hedblad B
Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
[TBL] [Abstract][Full Text] [Related]
3. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
Godtfredsen NS; Jørgensen DV; Marsaa K; Ulrik CS; Andersen O; Eugen-Olsen J; Rasmussen LJH
Respir Res; 2018 May; 19(1):97. PubMed ID: 29783959
[TBL] [Abstract][Full Text] [Related]
4. suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients.
Meyer J; Alstrup M; Rasmussen LJH; Schultz M; Ladelund S; Haupt TH; Tingleff J; Iversen K; Eugen-Olsen J
Scand J Trauma Resusc Emerg Med; 2018 Feb; 26(1):11. PubMed ID: 29391054
[TBL] [Abstract][Full Text] [Related]
5. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
Eugen-Olsen J; Andersen O; Linneberg A; Ladelund S; Hansen TW; Langkilde A; Petersen J; Pielak T; Møller LN; Jeppesen J; Lyngbaek S; Fenger M; Olsen MH; Hildebrandt PR; Borch-Johnsen K; Jørgensen T; Haugaard SB
J Intern Med; 2010 Sep; 268(3):296-308. PubMed ID: 20561148
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
[TBL] [Abstract][Full Text] [Related]
7. Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease.
Mehta A; Desai SR; Ko YA; Liu C; Dhindsa DS; Nayak A; Hooda A; Martini MA; Ejaz K; Sperling LS; Reiser J; Hayek SS; Quyyumi AA
J Am Heart Assoc; 2020 Mar; 9(5):e015457. PubMed ID: 32089048
[TBL] [Abstract][Full Text] [Related]
8. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
9. Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.
Koller L; Stojkovic S; Richter B; Sulzgruber P; Potolidis C; Liebhart F; Mörtl D; Berger R; Goliasch G; Wojta J; Hülsmann M; Niessner A
JACC Heart Fail; 2017 Apr; 5(4):268-277. PubMed ID: 28359415
[TBL] [Abstract][Full Text] [Related]
10. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
Hayek SS; Divers J; Raad M; Xu J; Bowden DW; Tracy M; Reiser J; Freedman BI
J Am Heart Assoc; 2018 May; 7(9):. PubMed ID: 29716888
[TBL] [Abstract][Full Text] [Related]
11. Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study.
Rasmussen LJH; Ladelund S; Haupt TH; Ellekilde GE; Eugen-Olsen J; Andersen O
Crit Care Med; 2018 Dec; 46(12):1961-1968. PubMed ID: 30247244
[TBL] [Abstract][Full Text] [Related]
12. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments.
Alstrup M; Meyer J; Schultz M; Rasmussen LJH; Rasmussen LS; Køber L; Forberg JL; Eugen-Olsen J; Iversen K
World J Surg; 2019 Mar; 43(3):780-790. PubMed ID: 30390135
[TBL] [Abstract][Full Text] [Related]
13. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.
Sehestedt T; Lyngbæk S; Eugen-Olsen J; Jeppesen J; Andersen O; Hansen TW; Linneberg A; Jørgensen T; Haugaard SB; Olsen MH
Atherosclerosis; 2011 May; 216(1):237-43. PubMed ID: 21354571
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
15. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
[TBL] [Abstract][Full Text] [Related]
16. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects.
Sørensen MH; Gerke O; Eugen-Olsen J; Munkholm H; Lambrechtsen J; Sand NP; Mickley H; Rasmussen LM; Olsen MH; Diederichsen A
Atherosclerosis; 2014 Nov; 237(1):60-6. PubMed ID: 25222341
[TBL] [Abstract][Full Text] [Related]
17. Cadmium exposure is associated with soluble urokinase plasminogen activator receptor, a circulating marker of inflammation and future cardiovascular disease.
Fagerberg B; Borné Y; Barregard L; Sallsten G; Forsgard N; Hedblad B; Persson M; Engström G
Environ Res; 2017 Jan; 152():185-191. PubMed ID: 27792942
[TBL] [Abstract][Full Text] [Related]
18. Healthy lifestyles reduce suPAR and mortality in a Danish general population study.
Haupt TH; Rasmussen LJH; Kallemose T; Ladelund S; Andersen O; Pisinger C; Eugen-Olsen J
Immun Ageing; 2019; 16():1. PubMed ID: 30679937
[TBL] [Abstract][Full Text] [Related]
19. Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.
Haastrup E; Grau K; Eugen-Olsen J; Thorball C; Kessing LV; Ullum H
PLoS One; 2014; 9(10):e110555. PubMed ID: 25329298
[TBL] [Abstract][Full Text] [Related]
20. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
